RE: Another recent patent for Clevegen10 May 2020 22:34
Quesera, with respect. IMO. Faron has up to presently got very little publicity. Traumakine will propel Faron so far just because attention has being drawn to It through this Coronavirus epidemic. But hopefully. Nobody Is going to forget It. In that Faron have spent a lot of time creating Traumakine for an Unmet medical condition, ARDS. Then out of the blue comes the Coronavirus and patients that die, It's ARDS that they die from. Don't forget It's a treatment Needed after the Virus Is ended. Just look where Traumakine not Clevegen has landed Faron. In the biggest Trial in the world. Why would a tiny pharma bring such focus on It self?. Well.. imo even though Traumakine Is It seems Mainly a treatment for ARDS. Someone Somewhere must have seen something In It to Warrant It's inclusion In that Trial. Clevegen so far so early seems to show Very promising results. So plenty to look forward to. Fingers crossed. IMO. That's the way I see It. Open to correction.